Amphetamine Cocaine Interaction Study - 2 - Full Text View

Amphetamine Cocaine Interaction Study - 2

This study has been terminated.
( P.I. left the institution )

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Texas
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000305

Purpose

The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Dextroamphetamine	Phase I

Drug Information available for:

8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Dextroamphetamine Dextroamphetamine sulfate Amphetamine Amphetamine sulfate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Amphetamine Cocaine Interaction Study

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000305

Locations


United States, Texas
	University of Texas Health Science Center
	Houston, Texas, United States, 77225

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Texas

Investigators


Principal Investigator:	John Grabowski, Ph.D.	University of Texas

More Information

Responsible Party:	University of Texas Medical School at Houston ( F. Gerard Moeller, M.D. )
Study ID Numbers:	NIDA-09262-2, P50-09262-2
First Received:	September 20, 1999
Last Updated:	August 18, 2008
ClinicalTrials.gov Identifier:	NCT00000305
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders

Dopamine

Mental Disorders

Dextroamphetamine

Substance-Related Disorders

Disorders of Environmental Origin

Amphetamine

Cocaine

Additional relevant MeSH terms:

Dopamine Uptake Inhibitors

Neurotransmitter Uptake Inhibitors

Neurotransmitter Agents

Molecular Mechanisms of Pharmacological Action

Adrenergic Agents

Sympathomimetics

Adrenergic Uptake Inhibitors

Physiological Effects of Drugs

Central Nervous System Stimulants

Pharmacologic Actions

Autonomic Agents

Therapeutic Uses

Dopamine Agents

Peripheral Nervous System Agents

Central Nervous System Agents

ClinicalTrials.gov processed this record on December 03, 2008